Scarica l'app Stockscreener
17.50
1.30%
-0.23
Dopo l'orario di chiusura:
17.50
Bioage Labs Inc Borsa (BIOA) Ultime notizie
Sectors Review: Can BioAge Labs Inc expand its profit marginsOptions Play & Daily Momentum Trading Reports - baoquankhu1.vn
BioAge Labs (BIOA) CMO Rubin sells $157k in shares - Investing.com UK
BioAge Labs (BIOA) CMO Rubin sells $157k in shares By Investing.com - Investing.com UK
BioAge Labs (NASDAQ: BIOA) CMO exercises options, sells 8,820 shares at $17.81 - Stock Titan
Risk Hedge: How do insiders feel about BioAge Labs IncWeekly Profit Report & Safe Entry Momentum Stock Tips - baoquankhu1.vn
BIOA PE Ratio & Valuation, Is BIOA Overvalued - Intellectia AI
Short Covering: Can BioAge Labs Inc lead its sector in growthWeekly Earnings Recap & Fast Gain Swing Trade Alerts - baoquankhu1.vn
BGE-102 data inspires confidence for BioAge Labs (BIOA) - MSN
Paul Rubin reports three 7,433-share sales (BIOA) in Form 144 - Stock Titan
BioAge Labs, Inc. (BIOA) stock price, news, quote and history - Yahoo Finance UK
BioAge Labs (NASDAQ:BIOA) Shares Up 8.7%Here's Why - marketbeat.com
BGE-102 Data Inspires Confidence for BioAge Labs (BIOA) - insidermonkey.com
Market Trends: Can BioAge Labs Inc expand its profit marginsTreasury Yields & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
Street Watch: Whats the beta of BioAge Labs Inc stock2026 EndofMonth & Weekly Top Stock Performers List - baoquankhu1.vn
BioAge Labs (BIOA) price target increased by 44.67% to 44.27 - msn.com
BioAge Labs (NASDAQ:BIOA) Shares Gap UpStill a Buy? - marketbeat.com
This Honeywell Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - benzinga.com
BioAge Labs (NASDAQ:BIOA) Coverage Initiated at Needham & Company LLC - marketbeat.com
Needham Initiates BioAge Labs at Buy With $50 Price Target - marketscreener.com
Needham Initiates BioAge Labs(BIOA.US) With Buy Rating, Announces Target Price $50 - Moomoo
Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (BIOA) and Establishment Labs Holdings (ESTA) - theglobeandmail.com
BioAge Labs: Early-Stage Promise in APJ Agonists Balanced by Execution Risk Supports Hold Rating - TipRanks
BioAge Highlights BGE-102 Progress and Financial Strength - theglobeandmail.com
Earnings Update: How correlated is BioAge Labs Inc to the S P5002026 Fed Impact & Short-Term Trading Alerts - baoquankhu1.vn
Price Action: Can BioAge Labs Inc. lead its sector in growth2026 Review & High Accuracy Trade Alerts - baoquankhu1.vn
Oppenheimer reiterates Outperform on BioAge Labs stock at $60 By Investing.com - Investing.com Australia
Jefferies reiterates Buy on BioAge Labs stock citing NLRP3 progress By Investing.com - Investing.com India
Jefferies reiterates Buy on BioAge Labs stock citing NLRP3 progress - Investing.com
BioAge Labs (NASDAQ: BIOA) registers shelf for future equity and debt offers - Stock Titan
Oppenheimer reiterates Outperform on BioAge Labs stock at $60 - Investing.com
BioAge Labs Full-Year 2025 Net Loss Narrows - Moomoo
BioAge Labs (NASDAQ:BIOA) Stock Price Down 9.8%Here's Why - MarketBeat
BioAge Labs Provides Business Updates - Lifespan Research Institute
BioAge Labs Reports Positive 2025 Financial Results and Advances BGE-102 NLRP3 Inhibitor Toward Phase 2 Trials in Cardiovascular and Ophthalmology Indications - Minichart
BioAge Labs, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
BioAge Labs 2025-2026 Pipeline: Advancing BGE-102 NLRP3 Inhibitor for Cardiometabolic Disease and Ophthalmology Based on Aging Biology Insights - Minichart
BIOAGE Labs Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Form 10-K BioAge Labs, Inc. For: Dec 31 - StreetInsider
BioAge Labs (NASDAQ: BIOA) boosts R&D and outlines cash runway to 2029 - Stock Titan
Earnings Flash (BIOA) BioAge Labs Posts 2025 Collaboration Revenue $9M, vs. FactSet Est of $7.1M - MarketScreener
Earnings Flash (BIOA) BioAge Labs Posts 2025 Net Loss $2.24 a Share, vs. FactSet Est of $1.89 Loss - MarketScreener
Earnings Flash (BIOA) BioAge Labs Posts 2025 Collaboration Revenue $9M, Vs. FactSet Est of $7.1M - Moomoo
BioAge Labs (NASDAQ: BIOA) widens 2025 loss but extends cash runway to 2029 - Stock Titan
BioAge Labs full-year collaboration revenue beats estimates - TradingView
BioAge Labs Reports Full Year 2025 Financial Results and Provides Business Updates from the Fourth Quarter of 2025 - ChartMill
BIOA Stock Price, Quote & Chart | BIOAGE LABS INC (NASDAQ:BIOA) - ChartMill
BioAge Labs, Inc.(NasdaqGS: BIOA) added to S&P Pharmaceuticals Select Industry Index - marketscreener.com
Certain Warrant of BioAge Labs, Inc. are subject to a Lock-Up Agreement Ending on 23-MAR-2026. - marketscreener.com
35,850,037 Stock Options of BioAge Labs, Inc. are subject to a Lock-Up Agreement Ending on 23-MAR-2026. - marketscreener.com
Certain Common Stock of BioAge Labs, Inc. are subject to a Lock-Up Agreement Ending on 23-MAR-2026. - marketscreener.com
BioAge Labs, Inc.: Fundamental Analysis and Financial Ratings | Y7G | US09077V1008 - MarketScreener
If You Invested $1,000 in BioAge Labs Inc. (BIOA) - Stock Titan
Jefferies upgrades BioAge Labs (BIOA) - MSN
BioAge Labs (NASDAQ:BIOA) Trading Down 5.9%What's Next? - MarketBeat
BioAge Makes a Comeback, Yet Technical Indicators Lean Bearish - Bitget
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):